VYYRF - Voyageur Pharmaceuticals Ltd. Receives $209764.05 from Exercise of Warrants and Options
(TheNewswire)
Calgary, Alberta - TheNewswire - March 10, 2021 - VoyageurPharmaceuticals Ltd. ( TSXV : VM ) ( OTC : VYYRF) (the "Company"or "Voyageur") announces that it has received $ 209,764.05 incash proceeds from the exercise of previously issued warrants,finder's warrants and stock options. The proceeds will be allocated tocontinue to move the Company forward towards cash flow.
Brent Willis, CEO of Voyageur, states “We are veryappreciative to all the shareholders who continue to support ourCompany. We would like to thank those shareholders who are exercisingtheir warrants prior to their pending expiry dates. We will continueto stay focused on cash flow and development of our F lag Ship property, Frances Creek”.
Voyageur Pharmaceuticals Ltd. is a Canadian publiccompany listed on the TSX Venture Exchange under the trading symbolVM. Voyageur is focused on the development of drugs related to theminerals barite and iodine as Active Pharmaceutical Ingredients("API") minerals. The near-term focus is developing bariumand iodine radiographic contrast products. Voyageur’s goal is toinitially generate positive cash flow from operations using thirdparty pharmaceutical manufacturers. Ultimately, Voyageur will bebuilding the required infrastructure to become 100% self-sufficientwith all manufacturing of drugs and API minerals. Voyageur owns a 100%interest in three barium sulfate (barite) projects including its 100%owned Frances Creek barium sulfate property and also owns interests inan iodine, lithium and bromine heavy mineral brine project located inUtah, USA. Voyageur is moving forward with its business plan ofbecoming the only fully-integrated company in the radiographiccontrast medical field by controlling all primary input costs underthe slogan of: "From theEarth to the Bottle".
For further information, pleasecontact:
Ron Love, CFO, Cell: (403) 818-6086, RonL@Vpharma.ca
Brent Willis, CEO, Brent@Vpharma.ca
www.voyageurpharmaceuticals.ca
Reader Advisory
Neither the TSXVnor its Regulation Services Provider (as that term is defined in thepolicies of the TSXV) accepts responsibility for the adequacy oraccuracy of this news release.
Forward Looking Information
This news release may contain certain forward-lookinginformation and statements, including without limitation, statementspertaining to the entering into of a definitive manufacturing contractwith AVL. All statements included herein, other than statements ofhistorical fact, are forward-looking information and such informationinvolves various risks and uncertainties. There can be no assurancethat such information will prove to be accurate, and actual resultsand future events could differ materially from those anticipated insuch information. A description of assumptions used to develop suchforward-looking information and a description of risk factors that maycause actual results to differ materially from forward-lookinginformation can be found in the Company's disclosure documents on theSEDAR website at www.sedar.com. Voyageur does not undertake toupdate any forward-looking information except in accordance withapplicable securities laws.
Copyright (c) 2021 TheNewswire - All rights reserved.